BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 18, 2014
View Archived Issues
Sichuan Haisco Pharmaceutical synthesizes novel FFAR1 agonists for diabetes
Read More
Novel animal models to study human neurological disorders
Read More
NetScientific invests in PDS Biotechnology
Read More
Taiho describes new androgen receptor antagonist for prostate cancer treatment
Read More
Prima BioMed initiates pilot trial of CVac in pancreatic cancer
Read More
Preclinical data for RG-7888 support phase I investigation
Read More
Capstone Therapeutics reports phase Ib/IIa study results for AEM-28
Read More
Novogen's TRXE-009 shows potential in melanoma
Read More
Stemline studies SL-401 in four rare myeloproliferative neoplasms
Read More
Isis studies ISIS-DMPKRx in new phase I/II trial for myotonic dystrophy type 1
Read More
Emergent BioSolutions acquires Evolva antibacterial program
Read More
Boston Strategics and MD Anderson sign risk-sharing agreement for study of E-6201
Read More
Preclinical results presented for BB-R12, a novel gene therapy for heart failure
Read More
Preliminary phase I/IIa data for an anticancer vaccine against multiple myeloma
Read More
A*STAR patents novel Wnt pathway modulators
Read More
Sumitomo Dainippon Pharma presents new dopamine D4 receptor agonists
Read More
Scientists at TransTech Pharma disclose novel Aurora kinase inhibitors
Read More
VPAC agonists show promising results as neuroprotectors in Parkinson's disease model
Read More
Velocity Pharmaceutical and Tigercat Pharma report phase II results for VPD-737
Read More
Yumanity Therapeutics launched to develop new therapies for neurodegenerative diseases
Read More
TxCell's Col-Treg receives E.U. orphan drug designation for non-infectious uveitis
Read More
Lundbeck discontinues development of desmoteplase
Read More
FDA approves ear drop formulation of finafloxacin for acute otitis externa
Read More
Poxel reports results from phase IIb trial of imeglimin in type 2 diabetes
Read More
Pozen receives second complete response letter from FDA regarding Yosprala
Read More